Cargando…

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

Between 2000 and 2005 several studies revealed that morphine is more potent and exhibits fewer side effects in beta-arrestin 2 knockout mice. These findings spurred efforts to develop opioids that signal primarily via G protein activation and do not, or only very weakly, recruit beta-arrestin. Devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mores, Kendall L., Cummins, Benjamin R., Cassell, Robert J., van Rijn, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478756/
https://www.ncbi.nlm.nih.gov/pubmed/31057409
http://dx.doi.org/10.3389/fphar.2019.00407